Clinuvel Pharmaceuticals
Clinuvel Pharmaceuticals Logo
About Clinuvel Pharmaceuticals
Clinuvel Pharmaceuticals Ltd is an Australian biopharmaceutical company specializing in the development and commercialization of treatments for genetic, metabolic, systemic, and life-threatening disorders, with a particular focus on dermatological conditions related to UV exposure. Its lead product, SCENESSE, is a systemic photoprotective drug for erythropoietic protoporphyria (EPP). The company’s pipeline includes alpha-melanocyte stimulating hormone analogues and other innovative therapies targeting skin and brain disorders. Clinuvel operates internationally, aiming to address unmet medical needs in photomedicine and related fields.
Address
535 Bourke Street, Level 22
Melbourne, 3000
Australia
Year founded
2000
Number of employees
0-100
Sector
Health Care
Industry Group
Pharmaceuticals, Biotechnology & Life Sciences
Industry
Biotechnology
Report inaccurate data
Request an update to help us keep the brand up-to-date.
